[Insightec in Parkinsons News Today] Exablate Neuro for Advanced Motor Symptoms Now Offered in Maryland
Based on trial findings, U.S. Food and Drug Administration (FDA) approval of the Insightec device was extended in November to treat moderate-to-severe motor complications, such as tremors, stiffness and dyskinesia (involuntary movement), in advanced disease patients who fail to respond to standard Parkinson’s therapies. Read more...
Read More